Mantzavinos T, Dalamanga N, Hassiakos D, Dimitriadou F, Konidaris S, Zourlas P A
2nd Dept. of Ob.-Gyn., University of Athens, Areteion Hospital, Greece.
Clin Exp Obstet Gynecol. 1993;20(2):111-5.
Eighty two consecutive IVF patients enrolled in our In-Vitro Fertilization program were investigated on the presence of anti-zona pellucida antibodies in the peripheral blood and follicular fluid, using a haemaglutination test (ovarian zona pellucida HAT) and a zona pellucida slide test, respectively. Overall higher proportion of antibody activity was observed in pregnant patients in both compartments (60% and 53%) in serum and follicular fluid, respectively) than the activity observed in non-pregnant (25% and 48%, respectively). There were no statistically significant differences found for the mean number of oocytes retrieved and fertilized irrespective of the presence of antibodies in serum or in follicular fluid, each one being taken into account separately. However, higher fertilization rates were observed in serum or follicular fluid antibody negative patients (68.2% and 71.2%, respectively) than those who were tested positive (36.6% and 65.4%, respectively). The same was true for the presence of anti-zona pellucida antibodies in serum and in follicular fluid, taking into consideration their presence or absence in both compartments simultaneously.
对连续纳入我们体外受精项目的82名患者,分别采用血凝试验(卵巢透明带血凝试验)和透明带玻片试验,检测其外周血和卵泡液中抗透明带抗体的存在情况。总体而言,血清和卵泡液中,妊娠患者抗体活性比例(分别为60%和53%)均高于未妊娠患者(分别为25%和48%)。无论血清或卵泡液中是否存在抗体,单独考虑时,所获卵母细胞数量和受精卵母细胞数量的平均值均无统计学显著差异。然而,血清或卵泡液抗体阴性患者的受精率(分别为68.2%和71.2%)高于检测阳性患者(分别为36.6%和65.4%)。同时考虑血清和卵泡液中抗透明带抗体的存在与否时,情况也是如此。